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AIM 
1. Age and sex incidence of gastric outlet obstruction. 
2. Pathological study on causes of gastric outlet obstruction. 
3. Correlate the results of upper gastrointestinal endoscopy, biopsy and 
peroperative findings in gastric outlet obstruction. 
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A PATHOLOGY STUDY ON GASTRIC OUTLET OBSTRUCTION                
INTRODUCTION 
  Gastric outlet obstruction is due to obstruction in first part of duodenum at 
the site of chronic scarring from ulceration or antrum where a benign gastric 
ulcer (type II and type III) or carcinoma is a problem. 
Stenotic complications of peptic ulcer disease are hour glass deformity and 
tea pot deformity (gastric ulcer). 
Stenotic complications arise from repeated cycles of ulceration and healing 
resulting in dense fibrosis with narrowing and deformity. 
Common causes of gastric outlet obstruction are  
1. Chronic duodenal ulceration / fibrosis, 
2. Antral gastric carcinoma, 
3. Carcinoma of the head of pancreas. 
Rare causes of gastric outlet obstruction  
1. Lymphomas, 
2. Crohn’s disease, 
3. Duodenal haematoma, 
4. Adult pyloric hypertrophy, 
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5. Annular pancreas, 
6. Mucosal diaphragm, 
7. Megaduodenum, 
8. Arteriomesenteric compression (Wilke’s disease). 
Clinical features of gastric outlet obstruction 
a. Abdomen pain, 
b. Upper abdominal discomfort, 
c. Vomiting (effortless, projectile, absence of bile, presence of partially 
digested food eaten hours or days previously), 
d. Constipation. 
SIGNS 
1. Malnourished, 
2. Dehydrated, 
3. Pallor, 
4. Succussion splash, 
5. Visible peristalsis, 
6. Dilated stomach. 
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Metabolic features: Hypochloraemic,  hyponatremic, hypokalemic, 
metabolic alkalosis. In late stage metabolic alkalosis with paradoxical acid 
urine occurs. 
The two common causes of  gastric outlet obstruction are                                                                                     
1. Gastric cancer,                                                                                                        
2. Pyloric stenosis secondary to peptic ulceration.  
ANATOMY                                                                                                                                                                          
STOMACH                                                                                                                          
Stomach is the widest part of the alimentary tract and lies between the 
oesophagus and the duodenum. The mean capacity of the stomach increases 
from approximately 30 ml at birth, to 1000 ml at puberty, and approximately 
1500 ml in adults.                                                                                                                               
PARTS OF THE STOMACH  
The stomach is divided   into fundus, body, pyloric antrum and pylorus. 
 VASCULAR SUPPLY AND LYMPHATIC DRAINAGE  
Arteries: The arterial supply to the stomach is from                                                                                     
1. The coeliac axis                                                                                                                          
2. The left gastric artery arises directly from the coeliac axis.                                                                                           
3. The splenic artery gives origin to the short gastric arteries and the left   
gastroepiploic artery.                                                                                                                                   
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4. The hepatic artery gives origin to the right gastric artery and to the 
gastroduodenal artery, which in turn gives origin to the right gastroepiploic 
artery. 
                                                          
                                                                                                                              
                                                                                                                                                                                                         
                                                                                               
 
 
 
 
 
 
                 
 
                                              Arterial supply of stomach 
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                                         Venous drainage of stomach 
 
                                           Lymphatics of stomach        
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INNERVATION  
The stomach is innervated by sympathetic and parasympathetic fibres. 
Sympathetic innervations: The sympathetic supply to the stomach originates 
from the fifth to 12th thoracic spinal segments, and is mainly distributed to 
the stomach via the greater and lesser splanchnic nerves via the coeliac 
plexus. Additional innervation comes from fibres of the hepatic plexus. The 
gastric sympathetic nerves are vasoconstrictor to the gastric vasculature and 
inhibitory to gastric musculature. The sympathetic supply to the pylorus is 
motor, and brings about pyloric constriction. The sympathetic supply also 
conducts afferent impulses that mediate sensations, including pain. 
Parasympathetic innervations: The parasympathetic supply to the stomach is 
from the anterior and posterior vagus nerves . The anterior vagus formed 
mainly from fibres from the left vagus originating from the oesophageal 
plexuses. The nerve divides near the oesophageal end of the lesser curvature 
into gastric and pyloric/hepatic branches. The upper anterior gastric branches 
radiate on the anterior surface of the upper body and fundus.  
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Anatomy of the anterior and posterior vagus nerves in relation to the 
stomach. 
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Secretion of acid 
DUODENUM                                                                                                                                                                                                                         
The adult duodenum is 20–25 cm long and is the shortest, widest part of the 
small intestine.It is only partially covered by peritoneum, the proximal 2.5 
cm is intraperitoneal, and the remainder is retroperitoneal. The head and 
uncinate  process of the pancreas lie within the concavity of the duodenum . 
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The duodenum lies entirely above the level of the umbilicus and is described 
as having four parts. 
 
 
 
       
   FIRST (SUPERIOR) PART: The first, and most mobile, part of the 
duodenum is about 5 cm long. It starts as a continuation of the duodenal end 
of the pylorus and ends at the superior duodenal flexure. The first 2 or 3 cm 
have a bland internal mucosal appearance and   referred as the duodenal 
‘cap'.                                                                                                             
SECOND (DESCENDING) PART :                                                                                     
The second part of the duodenum is 8–10 cm long. The common bile duct 
and pancreatic duct enter the medial wall obliquely and usually unite to form 
the common hepatopancreatic ampulla. The narrow distal end opens on the 
summit of the major duodenal papilla (ampulla of Vater), which is situated 
on the posteromedial wall of the second part, 8–10 cm distal to the pylorus. 
THIRD (HORIZONTAL) PART:The third part of the duodenum is 
approximately 10 cm long.                                                                                                               
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FOURTH (ASCENDING) PART: The fourth part of the duodenum is 2.5 
cm long. 
 VASCULAR SUPPLY AND LYMPHATIC DRAINAGE                                               
Arteries:                                                                                                                                          
Duodenum are supplied by the superior and inferior pancreaticoduodenal 
arteries. The first and second parts also receive contributions from the right 
gastric, supraduodenal, right gastroepiploic, hepatic and gastroduodenal 
arteries. Branches of the superior pancreaticoduodenal artery  supply  the 
pyloric canal. 
Veins                                                                                                                                                         
The duodenal veins drain ultimately into the portal vein.                                                                   
Lymphatics                                                                                                                              
Duodenal lymphatics run to anterior and posterior pancreatic nodes that lie 
in the anterior and posterior grooves between the head of the pancreas and 
the duodenum: and drain into                                                                                                                  
the supra-pyloric, infrapyloric, hepatoduodenal, common hepatic and 
superior mesenteric nodes. 
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INNERVATION  
The duodenum is innervated by both parasympathetic and sympathetic 
neurones.Preganglionic sympathetic axons originate from neurones in the 
intermediolateral columns of the grey matter in the fifth to the 12th thoracic 
spinal segments. They travel via the greater and lesser splanchnic nerves to 
the coeliac plexus where they synapse on neurones in the coeliac 
ganglion.postganglionic axons are distributed to the duodenal wall via 
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periarterial plexuses on the branches of the coeliac axis and superior 
mesenteric artery. The sympathetic nerves are vasoconstrictor to the 
duodenal vasculature and inhibitory to duodenal musculature. 
The preganglionic parasympathetic supply is carried by vagal axons that are 
distributed via the coeliac plexus and which synapse on neurones in the 
duodenal wall. The parasympathetic supply is secretomotor to the duodenal 
mucosa and motor to the duodenal musculature. The sympathetic nerves are 
vasoconstrictor to the duodenal vasculature and inhibitory to duodenal 
musculature. 
  PHYSIOLOGY 
The stomach stores food and facilitates digestion through a variety of 
secretory and motor functions.                                                                                                     
Acid Secretion 
PARIETAL CELL 
The parietal cell is stimulated to secrete acid  when one or more of three 
membrane receptor types is stimulated by                                                                                                                                
Acetylcholine (from vagal nerve fibers),                                                                                                        
Gastrin (from D cells), or                                                                                                                          
Histamine (from ECL cells). 
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The enzyme H+ /K+ -ATPase is the proton pump and is the final common 
pathway for gastric acid secretion.                                                                                       
PHYSIOLOGIC ACID SECRETION 
Food ingestion is the physiologic stimulus for acid secretion . The acid 
secretory response that occurs after a meal is described in three phases: 
cephalic, gastric, and intestinal. 
  CEPHALIC PHASE:                                                                                                                    
The cephalic or vagal phase begins with the thought, sight, smell, and/or 
taste of food. These stimuli activate several cortical and hypothalamic sites . 
The cephalic phase accounts for no more than 30% of total acid secretion in 
response to a meal. 
 GASTRIC PHASE:                                                                                                                                    
When food reaches the stomach, the gastric phase of acid secretion begins 
and accounts for about 60% of the total acid secretion in response to a meal.  
Amino acids and small peptides directly stimulate antral G cells to secrete 
Gastrin. Proximal gastric distention stimulates acid secretion via a vagovagal 
reflex arc. 
INTESTINAL PHASE:                                                                                                   
This phase starts when gastric emptying of ingested food begins, and 
continues as long as nutrients remain in the proximal small intestine. It 
accounts for about 10% of meal induced acid secretion. Interprandial basal 
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acid secretion is 2 to 5 mEq hydrochloric acid per hour, about 10% of 
maximal acid output (MAO), and it is greater at night. 
  Pepsinogen secretion                                                                                                                                    
The stimulus for pepsinogen secretion from chief cells is food ingestion; 
acetylcholine is the most important mediator.                                                              
Pepsinogen I is produced by chief cells.                                                                   
Pepsinogen II is produced by SECs. 
 Intrinsic Factor 
Activated parietal cells secrete intrinsic factor. Intrinsic factor binds to 
luminal vitaminB12, and the complex is absorbed in the terminal ileum via 
mucosal receptors. 
 Gastric Mucosal Barrier    (mucosal defences) :                                                               
Mucous barrier 
Bicarbonate secretion 
Epithelial barrier 
Hydrophobic phospholipids 
Tight junctions 
Restitution 
Microcirculation (reactive hyperemia) 
Afferent sensory neurons 
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Mediators:                                                                                                              
Prostaglandins                                                                                                                        
Nitric oxide 
Epidermal growth factor 
Calcitonin gene-related peptide 
Hepatocyte growth factor 
Histamine 
Gastrin-releasing peptide 
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Regulation of gastric acid secretion 
INTRINSIC GASTRIC INNERVATION 
The intrinsic innervation consists of ganglia and nerves that constitute the 
enteric nervous system.  
 Excitatory neurotransmitters:                                                                                                             
1. Acetylcholine, 2. Tachykinins,                                                                                                                                     
3. Substance P, and                                                                                                                                      
4. Neurokinin A. 
 Inhibitory neurotransmitters: 1. nitric oxide (NO) and 
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  2.  Vasoactive intestinal peptide (VIP).                                                                                                                                                                                                                                                           
Serotonin has been shown to modulate both contraction and relaxation.                                                                           
Specialized cells in the muscularis propria  are interstitial cells of Cajal , 
amplify both cholinergic excitatory and nitrergic inhibitory input to the 
smooth muscle of the stomach and intestine. 
SEGMENTAL GASTRIC MOTILITY 
 The proximal stomach regulates basal intra gastric tone, and the distal 
stomach mixes and grinds the food. The pylorus facilitates retropulsion of 
the solid food bolus back into the body of the stomach for additional 
breakdown. The pylorus  intermittently allow emptying of liquids and small 
solid particles into the duodenum. 
                                                                                                                                                            
When food is ingested, intragastric pressure falls as the proximal stomach 
relaxes. This proximal relaxation is mediated by two important vagovagal 
reflexes: receptive relaxation and gastric accommodation.                                                                                                                                                       
Receptive relaxation is the reduction in proximal gastric tone associated with 
the act of swallowing.  
Gastric accommodation is the proximal gastric relaxation associated with 
distention of the stomach.  
Slow waves of myoelectric depolarization sweep down the distal stomach at 
a rate of about three per minute.                                                                                                                                                                           
These waves originate from the proximal gastric pacemaker, high on the 
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greater curvature. During fasting, distal gastric motor activity is controlled 
by the migrating motor complex (MMC), the "gastrointestinal housekeeper". 
The MMC lasts approximately 100 minutes (longer at night, shorter during 
daytime) and is divided into four phases.                                                                                                                                                   
Phase I is a period of relative motor inactivity.                                                                                                                        
Phase II consists of some irregular, high amplitude, non propulsive 
contractions.                                                                                                            
Phase III, a period of intense, regular, propulsive contractions. 
 Phase IV is a transition period. 
GASTRIC EMPTYING (LIQUID EMPTYING)                                                                                             
The gastric emptying of water or isotonic saline follows first-order kinetics, 
with a half emptying time around 12 minutes. This emptying pattern of 
liquids is modified considerably as the caloric density, osmolarity, and 
nutrient composition of the liquid changes. Up to an osmolarity of about 1 
M, liquid emptying occurs at a rate of about 200 kcal per hour.  
SOLID EMPTYING 
Normally, the half-time of solid gastric emptying is <2 hours. Solids have an 
initial lag phase during which little emptying of solids occurs followed by a 
linear emptying phase follows, during which the smaller particles are 
metered out to the duodenum. 
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 PATHOPHYSIOLOGY 
DUODENAL ULCER 
Decreased duodenal bicarbonate secretion: 70% 
 
Increased nocturnal acid secretion: 70% 
 
Increased duodenal acid load: 65% 
 
Increased daytime acid secretion: 50% 
 
Increased pentagastrin stimulated maximal acid output: 40% 
 
Increased sensitivity to gastrin: 35% 
 
Increased basal gastrin: 35% 
 
Increased gastric emptying: 30% 
 
Decreased pH inhibition of gastrin release: 25% 
 
Increased postprandial gastrin release: 25% 
Modified Johnson Classification of Gastric Ulcers 
 
Type       Location                                                                Secretion 
  
I             Lesser curvature Low 
 
II           Body of the stomach and duodenum                     High 
 
III         Prepyloric (within 2-3 cm of the pylorus)              High 
 
IV        High on the lesser curve, near                                  Low 
             gastroesophageal junction 
 
V        Anywhere, induced by medication                            Low                                                  
Treatment of uncomplicated peptic ulcers                                                                                        
The aim of treatment is                                                                                                                                                           
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(i) to relieve symptoms;                                                                                                                                      
(ii) to heal the ulcer as quickly as possible;                                                                                                         
(iii) to prevent recurrence;                                                                                                                                  
(iv) to prevent complications. 
The classic triple therapy of 'bismuth', metronidazole, and amoxycillin 
(amoxicillin) for 2 weeks eliminates H. pylori in 90 per cent of patients.                                                                                                                                                    
A proton-pump inhibitor, with metronidazole 400 mg and amoxycillin 500 
mg three times a day, results in eradication rates of 85 to 95 per cent in 1 
week.                                                                                                                
If patients are allergic to amoxycillin, clarithromycin may be substituted; this 
antibiotic combined with ranitidine–bismuth citrate heals 93 per cent of 
patients.                                                                                                                        
For the 5 to 15 per cent that do not respond to the proton-pump inhibitor, 
bismuth should be added and the course extended for 2 weeks. 
QUDRAPLE THERAPY 
SURGERY                                                                                                                            
The goals of surgical procedures are to                                                                                            
1. Permit ulcer healing,                                                                                                                
2. Prevent or treat ulcer complications,                                                                                                  
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3. Address the underlying ulcer etiology,                                                                                        
4. Minimize postoperative digestive consequences. 
 SURGERY FOR INTRACTABLE DUODENAL ULCER 
 
 Vagotomy: 
  
1. Truncal Vagotomy: involves resecting a 2- to 3-cm section of the 
 
 anterior and posterior nerve trunks between the gastroesophageal  
 
junction and diaphragm. 
 
2. Selective Vagotomy: involves a bilateral vagotomy distal to the 
 
 branching of  the hepatic and celiac vagal branches. 
 
3. Highly selective Vagotomy: involves dividing the vagal branches to 
 
 the fundus  and body of the stomach while preserving the motor 
 
 branches to the antrum and  pylorus. 
Surgical techniques                                                                                                        
Intractable gastric ulcer :                                                                                                                  
Type I:                                                                                                                                 
Partial gastrectomy and Billroth I or Ulcer excision and Highly selective 
vagotomy.                                                                                                                              
Type II                                                                                                                                        
Truncal vagotomy and antrectomy or Highly selective vagotomy. 
  Type III                                                                                                                         
Truncal vagotomy and antrectomy                                                                                                
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Type IV                                                                                                                            
If ulcer within 2 cm of GE junction, Kelly-Madlener or  Csendes procedure,                         
For more distal lesions, Pauchet’s procedure  
TYPE V                                                                                                                                     
If medication cannot be stopped, excision and truncal vagotomy. 
                                BILLROTH I PARTIAL GASTRECTOMY                                                                                  
This is the standard operation for gastric ulcer. The distal stomach and 
pylorus, including the ulcer, is excised and an end-to-end gastro duodenal 
anastomosis is made to restore continuity.  A new lesser curve is made to 
narrow the stoma of the gastric remnant to the size of the duodenum.                                                               
PYLORIC PRESERVING SURGERY                                                                                       
The pyloric function is retained and therefore prevent the rapid gastric 
emptying and dumping that may occur when the pylorus is excised. About 
1.5 cm proximal to the pylorus is preserved with the pyloric branches of the 
vagus nerve. 
 
 
 
 Billroth II (Polya) partial gastrectomy                                                                               
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This can be used for both duodenal and gastric ulcers, and involves resecting 
two-thirds of the stomach, closing the duodenum distal to the pylorus 
(usually beyond the ulcer), and an end-to-side gastrojejunal anastomosis. 
VAGOTOMY AND ANTERECTOMY                                                        
Resection of the antrum (gastrin-secreting area) is used in addition to a 
truncal vagotomy. The re-anastomosis may be gastro duodenal or gastro 
jejunal, the gastro duodenal being preferable if the duodenum is not too 
scared. 
   Truncal vagotomy and pyloroplasty or gastro jejunostomy 
Truncal vagotomy is carried out as high as possible on the abdominal 
oesophagus above the area where the vagi start to branch. The peritoneum 
over the anterior surface of the oesophagus is divided and the phreno-
oesophageal ligament identified and elevated, exposing the anterior vagal 
trunk. The posterior trunk lies on the right posterior aspect of the 
oesophagus, often well away from the oesophageal wall, and the encircling 
finger around the oesophagus may pass medial to it and therefore it may be 
missed. A 1-cm piece is taken out of each of the trunks and the surgeon must 
carefully search the oesophageal wall for small branches. A 4 cm-long 
segment of the oesophagus should be denuded of its attachments. 
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Pyloroplasty: These are of several different types, for example Heineke–
Mikulicz, Finney (gastroduodenostomy), and ulcer-excluding. They all 
bypass or destroy the pyloric mechanism and so affect gastric emptying and 
duodenogastric reflex.                                                                                          
Anterior seromyotomy and posterior truncal vagotomy                                                            
The operation is based on the principle that only the anterior nerve to the 
antrum need be preserved to ensure antral function. In about 3 per cent of 
patients, the only supply to the antrum is from the posterior nerves, such that 
they would get delayed gastric emptying. 
LAPRASCOPY PROCEDURES: 
1.  Truncal vagotomy,                                                                                                                                
2. Gastroenterostomy,                                                 
3. Seromyotomy . 
DRAINAGE PROCEDURES                                                                                     
Pyloroplasty:                                                                                                                             
1.Heineke Mikulicz: A longitudinal incision through pylorus and 
reconstructing duodenotomy in transverse fashion.                                                                                                  
2. Finney: Indicated primarily for patients with a J-shaped stomach or 
extensive scarring and narrowing of a significant portion of the duodenal 
bulb.A  long incision from the stomach, through the pylorus, and well into 
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the duodenal bulb, with closure of the inferior duodenum to the inferior 
stomach and the superior duodenum to the superior stomach.                                                                                              
3. Jaboulay Gastroduodenostomy: The procedure involves anastomosis of the 
distal part of the stomach to the first and second portions of the duodenum, 
and bypassing the pylorus.                                                                                  
Gastrojejunostomy: Indicated as a drainage procedure when there is 
duodenal obstruction and the duodenal bulb is so scarred. 
  CARCINOMA OF STOMACH 
Epidemiology and aetiology 
Carcinoma of the stomach occurs predominantly between the fifth and 
seventh decades of life and in people in the lower socioeconomic groups. 
The variations in geographical incidence are not irrevocable, as 
environmental factors play an important part. 
  Site of gastric carcinoma                                                                                                          
The tumour is moving proximally, with a rising incidence of 
adenocarcinoma of the cardia. Tumours in the fundus are more aggressive, 
with a greater tendency to submucosal invasion regardless of the histological 
type. Proximally placed tumours have a worse prognosis than those sited 
distally because proximally placed tumours appear to be at a more advanced 
stage at presentation.                                                                                                                                       
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Aetiological factors                                                                                                          
Genetic                                                                                                                                                
E-cadherin, a cell-adhesion molecule, was poorly expressed in those patients 
who developed early, poorly differentiated, diffuse gastric cancer.                                                                                        
Aird, in 1953, described an association between blood-group A and gastric 
carcinoma. The relative risk over patients with blood group O is 1.2 times. 
This difference has been related to the nature of muco polysaccharide 
secretion in the stomachs of group-A individuals, and greater susceptibility 
to ingested carcinogens.                                                                                                
ENVIRONMENTAND DIET                                                                                             
Low-quality diets poor in milk, animal protein, and vitamins but rich in 
starch, heavily salted pickles, smoked fish and meats. These smoked foods 
contain polycyclic hydrocarbons (1,4-benzpyrene), which are the probable 
carcinogens.                                                                                                                          
In man ingested nitrates and nitrites present may be converted to 
nitrosamines (N-nitroso compounds) by the action gastrointestinal bacteria. 
Presence of atrophic gastritis and the associated achlorhydric stomach might 
predispose to the production of N-nitroso carcinogens. 
    PREMALIGANT CONDITION                                                                          
Mucosal atrophy and intestinal metaplasia .The first lesion is atrophic 
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gastritis, followed by progressive intestinalization of the mucosa to intestinal 
metaplasia, then dysplasia, and finally carcinoma. 
 HELICOBACTER PYLORI                                                                                                                                      
The particular subtype of H. pylori infection is becoming important. Infected 
individuals who had CagA antibodies were 5.8-fold more likely to develop 
gastric cancer, whereas those without CagA antibodies had an odds ratio of 
2.2. The most important strain has been characterized further as being 
CagAvacAS1a-positive.  
Primary low grade lymphoma of the mucosal associated lymphoid tissue 
(MALT) of the stomach. This tumour is strongly associated with H. pylori 
infection. 
  Strickland has divided chronic atrophic gastritis into two subgroups:                                                         
Type A, which is associated with pernicious anaemia, predominantly affects 
the fundus and body, and is autoimmune in origin.                                                                                                                                     
Type B affects the antrum and is related to environmental factors.                               
GASTRIC POLYPS                                                                                                 
Adenomatous polyps are truly premalignant. They are often larger (80 per 
cent greater than 2 cm), and are tubulovillous or villous on microscopic 
examination. PREVIOUS SURGERY                                                                                                                               
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The risk of developing gastric cancer following gastrectomy is reportedly 
between 3 and 10 per cent.   
 MENETRIER’S DISEASE                                                                                                           
Gastric carcinoma has been described as a complication of Menetrier 
disease. In Menetrier disease there is giant hyperplasia of the gastric mucosal 
folds.  
 Pathology                                                                                                               
The Borrmann classification: (By its macroscopic appearance).                               
Type I - Polypoid or fungating cancers,                                                                                             
Type II -Fungating and ulcerated and surrounded by elevated borders,                                                 
Type III -Ulcerated lesions infiltrating the gastric wall,                                                                          
Type IV- Cancers infiltrate diffusely, and                                                                                     
Type V -That are unable to be classified. 
The Lauren classification:Intestinal and Diffuse. 
                                                                  
The intestinal variant arises from the gastric mucosa and is glandular in 
origin. 
 
   Diffuse-type pathology appears to arise from the lamina propria. 
 
    The World Health Organization Classification: 
 
Depending on the degree of intestinal metaplasia. 
                                                
Adenocarcinoma (intestinal and diffuse), 
 
 Signet cell, 
30  
 
 Mucinous,  
 
 Tubular, and Papillary.  
 
      Risk Factors and Protective Factors in the Pathogenesis of Gastric 
Cancer  
                                                                                              
Intestinal variant 
 
Arises from precancerous areas (gastric atrophy, metaplasia) 
 
5:1 Male-to-female ratio 
 
Older population 
 
Dominant histology in areas where stomach cancer is epidemic  
 
Declining in incidence 
 
Diffuse Variant 
 
Women >> men 
 
Younger patients 
 
Higher association in familial occurrence (genetic cause) 
 
Major histologic type in endemic areas 
Worse overall prognosis  
    Acquired Factors 
 
1.High-salt diet 
 
2.High-nitrate diet 
 
3.Smoked/cured food 
 
4.Low vitamin A and C 
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5.Well water 
 
6.Cigarette smoking 
 
7.Helicobacter pylori 
 
8.Epstein-Barr virus 
 
9.Radiation exposure 
 
10.Previous gastric surgery 
 
11.Coal workers 
 
12.Rubber workers 
 
Genetic Factors 
 
1.Type A blood 
 
2.Pernicious anemia 
 
3.Family history 
 
4.Hereditary nonpolyposis colorectal cancer 
 
5.Li-Fraumeni syndrome 
 
Precursors 
 
1.Adenoma 
 
2.Atrophic gastritis 
 
3.Dysplasia 
 
4.Intestinal metaplasia 
 
5.Ménétrier’s disease 
 
Protective Factors 
 
1.Raw vegetables 
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2.Citrus fruits 
 
3.Antioxidants—vitamins A and C 
4.Selenium, zinc, iron,                                                                                                      
5.Green tea.                                                                     
 Precise description of the morphology of advanced gastric cancer by the 
Japanese has defined three types according to strict morphovolumetric types.                                                                                   
The ratio of the amount of muscle invasion to mucosal involvement gives                                                     
(i) a funnel type (mucosal greater than muscle involvement; ratio less than 
0.75),                                                   
(ii) a column type (equal involvement; ratio 0.75 to 1.25), and                                                                           
(iii) a mountain type (muscle greater than mucosal involvement; ratio greater 
than 1.25).  
MULTIPLE SYNCHRONOUS GASTRIC ULCER 
Multiple synchronous gastric cancer was described by Moertel, who defined 
strict criteria for diagnosis. Each lesion must be proved histo pathologically 
malignant, all lesions must be separated by normal gastric wall, and the 
possibility that the lesions represent a local extension or metastasis must be 
ruled out beyond reasonable doubt.  
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GASTRIC LYMPHOMA AND MALTOMA                                                         
Between 2 to 8 per cent of gastric malignancies are lymphomas .The initial 
stage preceding lymphoma is the excessive development of MALT 
('maltoma'). MALT an immunological defence system to control the local 
infection. It is clear that the pre neoplastic cells are proliferating in response 
to an antigenic stimulus that is T-cell dependent. The proliferation is 
composed of reactive T cells, plasma cells, and B cells, and mimics the 
appearance of lymphoid follicles in lymph nodes. Transformation from this 
low-grade tumour to high-grade lymphoma occurs when the mass becomes 
dominated by large blast cells.  
In gastric cancer, oncogenes coding for                                                                                                     
1.Tyrosine kinase receptors (c-met, c-erbB2),                                                                                   
2.Epidermal growth factor,                                                                                                              
3.Intracellular signal transduction (ras), and                                                                                                                               
4.Tumour suppressor genes (p53, APC)                                                                                                                  
have been identified as of potential significance of gastric cancer.  
    PATTERNS AND SREAD OF METASTASIS                                                                                                   
The poorly differentiated mucinous and signet-ring tumours are more 
invasive. Early gastric cancer with tumour confined to the mucosa and 
submucosa; those with poorly differentiated carcinomas are more prone to 
metastasis.  
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PENETRATION OF GASTRIC MUCOSA                                                                                  
If the muscularis propria and then the serosa are breached the tumour is 
likely to spread by transcoelomic implantation of shed cells.These cells 
characteristically become implanted in the ovaries, producing Krukenberg 
tumours (bilateral ovarian tumours from a signet-ring carcinoma), or in the 
pelvis, producing a shelf-like mass palpable rectally (Blummer's 
shelf).Gastric tumours may spread by direct extension and invasion of 
adjacent structures including liver, pancreas, spleen, peritoneum, mesentery, 
and omentum. 
   Lymphatic drainage and lymph-node involvement 
 Four zones of lymph drainage corresponding to the blood supply are 
identified.                                                                                                                                                    
Zone 1 is located in the gastrocolic omentum along the right gastroepiploic 
vessels,                                                                                                                   
draining to the pylorus and then to coeliac and aortic nodes.                                                                             
Zone 2 is in the gastrocolic and gastrosplenic omentum around the left 
gastroepiploic vessels, draining  to the pancreaticosplenic lymph nodes and 
to the aortic nodes.                                                                                                                               
Zone 3 surrounds the left gastric artery and drains into perioesophageal 
lymph nodes.                                                                                                                                                                                                       
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Zone 4 drains along the hepatic artery and drains into para-aortic lymph 
nodes. 
The Japanese have adjusted and stratified the classification of lymph 
drainage. 
 GroupI  (N1) are perigastric lymph nodes;                                                                                                
Group II (N2) are nodes along and at the roots of the major vessels;                                                        
Group III (N3) are lymph nodes at the root of the superior mesenteric artery, 
in the hepaticoduodenal ligament, and behind the pancreas; and                                                                                                         
Group IV (N4) are distant lymph nodes.                                                                    
1. Right cardial                                                                                                                           
2. Left cardial                                                                                                                              
3. Lesser curvature                                                                                                                                   
4. Greater curvature                                                                                                                    
5. Supra pyloric                                                                                                                     
6. Infra pyloric                                                                                                                          
7. Left gastric                                                                                                             
8. Common hepatic 
9. Celiac 
 
10. Splenic hilus 
 
11. Splenic artery 
 
36  
12. Hepatoduodenal ligament 
 
13. Retropancreatic 
 
14. Mesentric root 
15. Trancsverse mesocolon 
16. Para aortic 
                                                                                                                                        
AJCC STAGING OF GASTRIC CARCINOMA 
 
 Tumor 
 
T1 Tumor invades the lamina propria or submucosa 
 
T2 Tumor invades the muscularis propria (a) or submucosa (b) 
 
T3 Tumor invades through the serosa without invading adjacent structures 
 
T4 Tumor directly invades adjacent structures 
 
Lymph Nodes 
 
N0 0 lymph nodes 
 
N1 1 to 6 positive lymph nodes 
 
N2 7 to 15 positive lymph nodes 
 
N3 >15 positive lymph nodes 
 
 
Distant Metastases 
 
M0 No distant metastases 
 
M1 Distant metastases 
 
TNM Grouping 
 
Stage IA T1, N0, M0 
 
37  
Stage IB T1, N1, M0 
 
          T2a, N0, M0 
 
          T2b, N0, M0 
 
Stage II   T1, N2, M0 
 
                T2a, N1, M0 
 
                T2b, N1, M0 
 
                T3, N0, M0 
 
Stage IIIA   T2a, N2, M0 
                    T2b, N2, M0 
 
                     T3, N1, M0  
 
                     T4, N0, M0 
 
Stage IIIB     T3, N2, M0 
 
Stage IV Any T4 + any N1, Any N3 or M1 
CLINICAL FEATURES                                                                                                  
1.Abdomen pain,                                                                                                                     
2.Nausea,                                                                                                                                       
3.Vomiting,                                                                                                                                 
4.Loss of weight,                                                                                                              
5.Anorexia,                                                                                                                     
6.Early satiety. 
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SIGNS 
1.Palpable abdominal mass, 
2.Ascites, 
3.Blumer’s shelf nodules, 
4.Krukenberg tumors, 
5.Periumbilical lymphadenopathy (Sister Mary Joseph’s Nodule), 
6.Palpable supra clavicular lymphadenopathy(Virchow’s node). 
7.Radiography,                                                                                                                      8.Barium contrast studies of the upper gastrointestinal tract,                                                                                      9.The double-contrast, air–barium study ,                                                                                                   10.Computed tomography (CT),                                                                                                   11.Ultrasonography, and                                                                                                                                        12.Magnetic resonance imaging ,                                                                                              13.Imunolocalization with monoclonal targeted isotopes,                                                                       14.Endoscopic lymphography,                                                                                                              15.Endoluminal ultrasonography, and                                                                                                                                                       16.Dynamic CT,                                                                                                                                          17.Endoscopic ultrasonography, 
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18.Positron emission tomography (PET) with fluorodeoxyglucose (FDG), 
19.Endoscopy and biopsy. 
The development of fibreoptic, flexible, forward-viewing endoscopes with a 
controllable tip has been a major advance. It allows direct visualization of 
the stomach and accurate biopsy of any lesion identified. If up to 10 biopsies 
were taken from each lesion, the diagnostic accuracy was 100 per cent. The 
working recommendation is that four to six biopsies be taken from each 
lesion, and from the inner border of the edge of any ulcer. 
Improvements in endoscopic techniques include                                                                                            
1.Dye-spraying,                                                                                                                                      
2.Fluorescence endoscopy,   
3. Magnified endoscopy,                                                                                                                                     
4.Electronic endoscopy,                                                                                                                               
5.Endoscopic ultrasonography. 
6.Magnified endoscopy, 
7.Electronic endoscopy, and                                                                                                                               
8.Endoscopic ultrasonography. 
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 Endoscopic Instrumentation and Patient Preparation: Flexible endoscopes 
now use fiber optics only for transmission of light, and the image is 
transmitted via a CCD (charge-coupled device) computer chip at the tip of 
the endoscope. Flexible endoscopes with smaller outer diameters and larger 
biopsy channels have resulted in better patient tolerance and comfort and the 
performance of complex interventions. Double-channel endoscopes allow 
“two handed techniques” such as mucosal resection and tissue 
approximation in the absence of more effective endoscopic suturing devices. 
Preparation for diagnostic and therapeutic endoscopy of the stomach requires 
merely 6 to 8 hours of fasting before the procedure. Patients with gastric 
outlet obstruction or profound gastroparesis require a longer period of 
fasting, and tube decompression before the procedure may be prudent. 
Delivery of conscious sedation requires adequate monitoring with pulse 
oximetry, blood pressure recordings, and regular documentation of 
respiration. As the endoscope advances into the stomach, it assumes a 
“greater curve position,” with the posterior wall at 3 o’clock, the greater 
curvature at 6 o’clock, the anterior wall at 9 o’clock, and the lesser curvature 
in the 12- o’clock position. When the scope is initially advanced into the 
stomach, rugal folds are identified in the fundus and body and are typically 
absent at the junction of the distal body and antrum. Evaluation of the 
incisura angularis is important to rule out type I gastric ulcers. A side-
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viewing endoscope is necessary to obtain a full endoscopic view of this 
portion of the duodenum.                                                                                                                                                                                 
Gastric Pathology 
Gastric ulcers may be identified in the prepyloric, body, and fundic portions 
of the stomach and angularis. Gastric ulcers found at the time of endoscopy 
require aggressive biopsy of all margins at the junction of the edges of the 
base and surrounding gastric mucosa Suspicion of malignancy may be 
supported by the presence of heaped edges, deeper ulcerated bases, or diffuse 
infiltrative processes. Follow-up endoscopy within 8 to 12 weeks is 
necessary for ulcers that are benign by initial biopsy but have an atypical 
appearance, are larger than 2 cm, appear suspicious pathologically, or are 
leading to persistent symptoms. Absence of healing at the time of second 
endoscopy may be an indication for surgical excision 
   Cytology                                                                                                                      
Cytological study of gastric aspirate for exfoliated malignant cells has been 
used in patients with advanced disease, but has a variable accuracy of 
between 40 to 90 per cent.                                                                                                                                              
Methods of collecting the cytological specimen include                                                                                      
1.Gastric washings,                                                                                                                                            
2.Washings with the addition of a mucolytic agent, and                                                                                                                 
3.The passage of a balloon.                                                                                                            
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Cytological analysis of brushings directly collected from suspicious lesions 
can alone be accurate in 81 per cent, but when combined with biopsy has an 
improved accuracy of 91 per cent.  Immunocytochemical stains such as fetal 
sulfaglycoprotein may be useful for cytological preparations. Serum tumor 
markers, including carcinoembryonic antigen (CEA), CA 19-9, CA-125, CA 
72-4, and human chorionic gonadotropin (HCG), can be elevated in patients 
with gastric cancer, although the individual sensitivities are generally low—
in the 40% to 50% range. 
 TREATMENT AND OUTCOME                                                                     
ONCOLOGICAL APPROACH                                                                                        
FACTORS AFFECTING PROGNOSIS                                                                                                                                                                                                                                                                                                                                                                       
There are undoubtedly predetermined factors that govern survival,                                                            
1.The site of the tumour,                                                                                                                                                          
2.The extent of nodal and,                                                                                                                                  
3.Serosal involvement,                                                                                                                                                    
4.The manner of execution of the resection.                                                                                                              
Poor prognostic factors in relation to the presentation of the tumour are                                               
1.Serosal invasion,                                                                                                                                                         
2.Presence of lymph-node metastasis,                                                                                                                            
3.Presence of free carcinoma cells in the peritoneum,                                                                                                     
4.Lauren's classification (intestinal type better than diffuse type),                                                                          
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5.Cardial tumour,                                                                                                                                              
6.Histological evidence of the invasion of lymph vessels,                                                                         
7.Tumour stage,                                                                                                                                                            
8.Tumour depth and size, and                                                                                                                                                  
9.Patient's age.                                                                                                                                                            
The poor prognostic variables that relate to surgery are                                                                             
1.Positive resection margins,                                                                                                                                
2.Inadequate extent of lymphadenectomy, and                                                                                                                     
3.Associated splenectomy.                                                                                                                           
The basic oncological approach for resection of mucosal cancers is wide 
excision of the primary tumour with en bloc removal of the draining network 
of lymph node. 
ENDOSCOPIC LOCAL EXCISION 
The Japanese in particular have pioneered endoscopic local excision of early 
gastric cancer. The technique involves the use of an endoscopic snare, with 
pathological assessment of the adequacy of excision. If the lesion is not 
amenable to removal by snare, the injection of saline beneath it may allow its 
removal. Laser ablation is an alternative, but fails to allow histological 
analysis; it can be used to treat tumours that penetrate deep into the 
submucosa.  
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                                    EXTENT OF GASTRIC RESECTION 
Adequate gastrectomy implies surgical margins in the stomach free of 
tumour; thus gastrectomy may be partial or subtotal if the tumour is distal, or 
total if it is more proximal. The definition of adequate resection margins is 
an 5- to 6-cm clearance proximally and 2cms distally in the unstretched 
stomach. Failure to resect the stomach widely with microscopically clear 
margins is highly detrimental to survival. If the resection margin is not 
confirmed free of microscopic disease, the prognosis of a stage-II tumour 
falls to that of a stage IV. In general, multiple cancers should be treated by 
total gastrectomy. 
Lesions in the body and fundus of the stomach present different problems. 
Total gastrectomy is often advocated in these circumstances because the 
small amount of stomach that remains has little reservoir capacity. Both 
procedures require an oesophagoenteric anastomosis. Total gastrectomy with 
a Roux-en-Y reconstruction is also superior to proximal gastrectomy since 
these patients will be less prone to alkaline and biliary reflux. Tumours of 
the body and fundus are often far advanced at presentation because they 
reach considerable size before producing symptoms. They have a less 
favourable prognosis than tumours in the antrum. 
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The preferred method of reconstruction after total gastrectomy is as a Roux-
en-Y with a 60-cm Roux to prevent bile reflux. The creation of a pouch to 
act as a reservoir to prevent early satiety has been advocated. The Hunt–
Lawrence pouch is created from a long Roux loop with an enteroenteric 
anastomosis at 80 cm. It is simply folded on itself and a 10 cm, side-to-side 
anastomosis created below the oesophageal anastomosis. A partial 
gastrectomy is best reconstructed as an antecolic, Polya type of gastrectomy. 
Lymph nodes removed in D1 versus D2 versus D3 lymphadenectomy during 
resection of gastric cancer. 
Reconstruction After Gastrectomy 
After distal subtotal gastrectomy,                                                                                                                                           
Billroth I gastroduodenostomy, 
Billroth II gastrojejunostomy (either antecolic or retrocolic), and                                                                                                                 
Roux-en-Y gastrojejunostomy (also either antecolic or retrocolic). 
 
 After total gastrectomy, options for reconstruction include a standard                                                                                                           
Roux-en-Y esophagojejunostomy,                                                                                                                                         
Construction of a pouch, and                                                                                                                                                      
Jejunal interposition                                                                                                                                                                       
Anastomosis can be done in a stapled fashion ( circular or linear) or hand 
sewn in one or two layers. 
46  
 When constructing an esophagojejunostomy, one may use a jejunal pouch to 
provide for a neostomach reservoir.  
 
Adjuvant Therapy                                                                                                             
1.Adjuvant Chemotherapy                                                                                          
Combination chemotherapy with  5-fluorouracil (5-FU), epirubicin, 
mitomycin, and methyl-CCNU have been  associated with  better response 
rates. 
2.Adjuvant Chemoradiotherapy 
5-FU/leucovorin (LV), followed by 45 Gy radiotherapy, followed by 
additional 
5-FU/LV. 
3.Adjuvant Intraperitoneal Therapy                                                                               
Continuous hyperthermic peritoneal perfusion (CHPP) has been used in 
patients with gastric cancer in both the adjuvant and palliative setting. Drugs 
used are 5 flurouracil, mitomycin-c, cisplatin.                                                                                   Neoadjuvant Therapy                                                                                                            1. Neoadjuvant Radiotherapy   
     The radiotherapy group had a higher overall resection. Tumor down-
sizing and nodal down-staging were also noted, and there was no increase in 
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operative mortality with the use of preoperative radiotherapy.patient with 
node-positive disease and T4 lesions had a significant survival advantage 
with the radiotherapy regimen, and again there was no increase in 
perioperative mortality or morbidity. 
                                                                                                                                                                                                                          2. Neoadjuvant Chemotherapy                                                                                   
Neoadjuvant drugs are etoposide, cisplatin, and 5-FU. A higher proportion of 
patients in the chemotherapy group underwent curative resection and were 
noted to have significantly smaller tumors at surgery, as well as 
significantly lower T and N stages. 
3. Neoadjuvant Chemoradiotherapy 
5-Fluorouracil, folinic acid, and cisplatin, followed by 5 Fluorouracil 
potentiated radiotherapy (45 Gy). Surgical resection after this preoperative 
regimen was safe, with a complete pathologic response in 30% and a partial 
pathologic response in 24%. 
 Management of Advanced Disease 
Surgical palliation may include resection alone or in combination with 
endoscopic, percutaneous, or radiotherapeutic interventions or chemotherapy 
and radiotherapy.  
Surgery for Palliation 
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Exploratory laparotomy alone, GI bypass, or palliative resection, resection 
was associated with longer survival in patients with both local and distant  
spread of 
disease.          
Endoscopic Palliation                                                                                                                   
In patients who are not good candidates for palliative resection but have 
symptoms of obstruction, endoscopic palliative techniques may be useful, 
including placement of metal expandable stents and laser recanalization, 
dilatation or stenting. 
 After relief of obstruction, many of these patients can later receive palliative 
chemotherapy. 
Palliative Chemotherapy 
 Multiagent chemotherapy  cisplatin, paclitaxel, and irinotecan given to all 
patients with advanced disease who have reasonable performance status. 
Palliative Radiotherapy                                                                                                                                               
It is effective in controlling symptoms such as bleeding and pain, most 
patients have diffuse metastatic disease.  
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OBSERVATIONS AND RESULTS  
 
 
AGE IN YEARS NUMBER OF 
PATIENTS 
PERCENTAGE 
<50 15 41 
50-55 8 24 
56-60 4 12 
61-65 5 15 
>65 3 9 
 
Gastric outlet obstruction is common in age less than 50 years is 14 (40%). 
In 10 patients it is due to malignancy and in 4 patients it is due to benign 
lesion. In age between 50 to 55 years 8 pateints (24%) develop gastric outlet 
<50 
41% 
50-55 
24% 
56-60 
12% 
61-65 
15% 
>65 
9% 
AGE IN YEARS 
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obstruction. In   7 patients the cause is malignant lesion and in one patient 
the cause is cicatrized   duodenal ulcer in 1st part of duodenum. In age 
between 56 to 60 years 4 patients had gastric outlet obstruction and in all 4 
patients cause was malignant lesion.  In age between 61 to 65 years 5 
patients had gastric outlet obstruction. In 3 patients the cause is malignant 
lesion and in 2 patients it was due to benign lesion. In age above 65 years 3 
patients develop gastric outlet obstruction and the cause is malignant lesion. 
In this study young age to develop gastric outlet obstruction is 30 years due 
to cicatrized duodenal ulcer and oldest age is 75 years due to gastric 
carcinoma. The age incidence is 30 to 75 years with mean of 52.5 years. The 
young age to develop gastric carcinoma is 35 years.   
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SEX RATIO 
SEX NUMBER OF 
PATIENTS 
PERCENTAGE 
MALE 20 57 
FEMALE 14 43 
 
Gastric outlet obstruction is common in male patients. In this study 20 male 
patients (57%) develop gastric outlet obstruction. In 14 male patients the 
cause is malignant lesion and in 6 male patients it is due to benign lesion. 14 
female patients (43%) develop gastric outlet obstruction. In 12 female 
patients the cause is malignant lesion and in 2 female patients it is due to 
benign lesion. In this study malignancy is most common cause of gastric 
outlet obstruction in both sexes. In this study in age less than 60 years gastric 
MALE 
57% 
FEMALE 
43% 
SEX RATIO 
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outlet obstruction is more common in female patients (14 female patients 
and 12 male patients). 
 In this study 3 male patients (100%) above 65 years develop gastric outlet 
obstruction. In age between 50 to 55years the cause of gastric outlet 
obstruction is equal in both sexes (4 patients in each sex).  
 ETIOLOGY 
 
ETIOLOGY OF GASTRIC OUTLET OBSTRUCTION 
CAUSES OF GASTRIC 
OUTLET 
OBSTRUCTION 
NUMBER OF 
PATIENTS 
PERCENTAGE 
CARCINOMA 26 74 
DUODENAL ULCER 7 20 
GASTRIC ULCER 1 6 
CARCINOMA 
74% 
DUONENAL ULCER 
20% 
GASTRIC ULCER 
6% 
CAUSES OF GASTRIC OUTLET OBSTRUCTION 
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In this study gastric carcinoma in pyloric region is the common cause of 
gastric outlet obstruction in 26 patients (74%). In 8 patients the cause is 
benign lesion. In 7 patients the cause is cicatrized duodenal ulcer in 1st part 
of duodenum. In 1 patient it is due to chronic gastric ulcer in pyloric region.    
 
BLOOD GROUP NUMBER OF 
PATIENTS 
PERCENTAGE 
A 9 23 
B 13 41 
AB 4 12 
O 8 24 
 
A 
23% 
B 
41% 
AB 
12% 
O 
24% 
BLOOD GROUP DISTRIBUTION 
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In this study majority of patients (14) were having blood group B (41%) and 
next common in blood group is A (23%). In benign lesion 4 patients had B 
blood group, 2 patients had O blood group, 1 patient had AB and A blood 
group each. In malignant lesion 10 patients had B blood group, 7 patients 
had A blood group, 6 patients had O blood group, 3 patients had AB blood 
group. 
 
SYMPTOMS NUMBER OF 
PATIENTS 
PERCENTAGE 
ABDOMEN PAIN 31 91.1 
VOMITING 33 97 
ANOREXIA 30 88.2 
HAEMETEMESIS 7 20.5 
MALENA 5 14.7 
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In this study the common symptom in gastric outlet obstruction was 
vomiting in 33 patients (97%). Vomiting is projectile, effortless, non bilious 
and vomitus contains undigested food particles. In 7 patients vomiting was 
blood stained and 5 patients had history of passing black tarry stools. The 
next complaint was abdomen pain (91.1%) followed by anorexia (88.2). Pain 
was dull aching in nature. In case of carcinoma stomach pain was aggravated 
immediately after food intake and relived by vomiting. In duodenal ulcer 
patients abdomen pain appears 2 hours after food intake and relieved by 
taking food or medicines. In 30 patients they had a history of reduced food 
intake. Patients developed early satiety and pain after taking food.       
 
Note: VGP: Visible gastric peristalsis 
SP: Succussion splash 
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SIGNS NUMBER OF PATIENTS PERCENTAGE 
PALLOR 22 64.7 
DEHYDRATION 27 79.4 
VISIBLE PERISTALSIS 12 35.2 
SUCCUSSION SPLASH 14 41.1 
WEIGHT LOSS 23  67.6 
 
The common sign in gastric outlet obstruction was dehydrated and 
malnourished patients (79.4%). Next common sign is pallor (64.7%). Visible 
gastric peristalsis is seen 12 (35.2%) patients. In 14 (41.1%) patients 
succession splash was present. Patients with gastric carcinoma were more 
malnourished and dehydrated than patients with benign lesion. Patients with 
gastric carcinoma lost weight in short duration than benign lesion.  
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ENDOSCOPY NUMBER OF 
CASES 
PERCENTAGE 
ULCEROPROLIFERATIVE 15 46 
ULCERATIVE 9 27 
POLYPOID 2 3 
DUODENAL ULCER 3 9 
PYLORIC STENOSIS 4 12 
DUODENUM 
DILATATION 
1 3 
 
All the patients were subjected to endoscopy and biopsy. Ulceroproliferative 
growth was present in 15 patients. 1n 9 patients it was of ulcerative growth. 
In 4 patients endoscopy could not be passed beyond pyloric end. 2 patients 
had polypoid growth in pyloric region. In one patient 1st and 2nd part of 
duodenum was dilated. In all patients biopsy was taken and sent for 
histopathology study.  
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SURGERY NUMBER OF CASES PERCENTAGE 
AGJ 14 41 
TV/PGJ 7 20 
PG/GJ 6 18 
DG/GJ 3 9 
TG/OJ 2 6 
SG/GJ 1 3 
FJ 1 3 
 
AGJ- ANTERIOR GASTRO JEJUNOSTOMY 
DG/GJ- DISTAL GASTRECTOMY, GASTRO JEJUNOSTOMY 
AGJ 
41% 
TV/PGJ 
20% 
PG/GJ 
18% 
DG/GJ 
9% 
TG/OJ 
6% 
SG/GJ 
3% 
FJ 
3% SURGERY 
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TV/PGJ- TRUNCAL VAGATOMY, POSTERIOR 
GASTROJEJUNOSTOMY 
TG/OJ-TOTAL GASTRECTOMY,   OESOPHAGOJEJUNOSTOMY 
PG/GJ- PARTIAL GASTRECTOMY, GASTRO JEJUNOSTOMY 
SG/GJ- SUB –TOTAL GASTRECTOMY, GASTRO JEJUNOSTOMY 
FJ- FEEDING JEJUNOSTOMY 
Truncal vagotomy with posterior gastro jejunostomy was done for patients 
with  duodenal ulcer and gastric outlet obstruction. Among carcinoma 
stomach patients 6 of them underwent partial gastrectomy with 
gastrojejunostomy. In 2 patients carcinoma stomach total gastrectomy with 
oesophagus jejunum anastomosis was done. In 3 patients of gastric 
carcinoma distal gastrectomy with gastrojejunsotomy was done. In one 
patient with gastric carcinoma subtotal gastrectomy was done. In 14 patients 
advanced gastric carcinoma palliative anterior gastrojejunsotomy was done. 
Palliative procedure was done because the tumor was inoperable during 
surgery. In 1 patient with advanced gastric carcinoma feeding jejunostomy 
was done. Per operative finding was identified and noted. Specimen was sent 
for histopathology study.      
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BIOPY REPORT NUMBER OF 
PATIENT 
PERCENTAGE 
WDA 2 6 
MDA 14 41 
PDA 10 29 
HYPERTROPHIED 
NERVE BUNDLE 
7 21 
GASTRIC ULCER 1 3 
WDA- WELL DIFFERENTIATED ADENOCARCINOMA 
MDA- MODERATELY DIFFERENTIATED ADENOCARCINOMA 
PDA - POORLY DIFFERENTIATED ADENOCARCINOMA 
In this study the biopsy reports of the specimen were 
 14 patients had moderately differentiated adenocarcinoma, 
 10 patients had poorly differentiated adenocarcinoma, 
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  2 patients had well differentiated adenocarcinoma, 
7 patients had hypertrophied nerve bundle of vagus nerve, 
1 patient had chronic gastric ulcer. 
 
PEROPERATIVE FINDING 
In benign lesion 4 patients had dilated stomach with cicatrized ulcer in 1st 
part of 
 duodenum. 3 patients had dilated stomach with cicatrized ulcer in pyloric 
antrum. 
 One patient had ulcer in pyloric antrum with stenosis in pylorus region.                               
In malignant lesion 14 patients had growth in pyloric region with dilated 
stomach. In 4 patients there was ulceroproliferative growth in pyloric region. 
2 patients had ulcerative mass in pyloric region. 2 patients had mass in 
pyloric antrum with tumor fixed to posterior stomach bed structures and the 
tumor was in operable. 2 patients had metastases to liver, sigmoid colon, 
omentum, peritoneal deposits and the tumor was inoperable. One patient had 
polypoid growth in pyloric region. In one patient there was ascites with 
serosal involvement and the tumor was inoperable.  
MATERIALS AND METHODS 
This was a pathological study on gastric outlet obstruction comprising of 34 
cases of gastric outlet obstruction. The patients have been selected from 
Tirunelveli Medical College Hospital in the Surgery department from 
December 2010 to December 2011. 
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The cases were selected with following inclusion and exclusion criteria. 
Inclusion Criteria 
1. Peptic ulcer disease with gastric outlet obstruction. 
2.  Carcinoma pyloric region with gastric outlet obstruction. 
Exclusion Criteria 
1. Infantile hypertrophic pyloric stenosis 
2. Congenital lesion 
3. Gastro intestinal tuberculosis 
An elaborate study of all the patients with regard to history, clinical features, 
routine investigations, endoscopy and biopsy report,  pre operative 
management, per-operative findings, post operative management and 
complications during post operative period is managed. Patient general 
condition, nutrition status, hydration and co-morbid conditions were 
managed before surgery. 
Complete haemogram, blood urea, serum creatinine, serum electrolytes, 
electro cardiogram, chest x-ray, blood grouping and Rh typing, bleeding 
time, clotting time, blood sugar (fasting and post prandial), was done. Ultra 
sonogram of abdomen and pelvis, upper gastro intestinal endoscopy and 
biopsy from the lesion, were taken. Biopsy sent for histopathological study. 
Criteria for diagnosing the patient clinically by 
1. Abdomen pain, 
2. Vomiting (projectile, non bilious, undigested food particles), 
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3. Anorexia, 
4. Malnutrition, 
5. Visible gastric peristalsis, 
6. Succussion splash, 
7. Palpable mass, 
8. Loss of weight.  
Preoperative management 
Patient general condition, anaemia, hydration, electrolyte imbalance, 
comorbid conditions were managed. Informed consent obtained and patient 
was prepared for surgery. 
Post operatively patients were monitored under intensive care. Half hourly 
pulse, temperature, respiratory rate chart , 4th hourly blood pressure chart, 
input and output chart, ryles tube aspiration, drain collection, soakage of 
dressing were maintained.  
Higher antibiotics, analgesics, H2 blockers, proton pump inhibitors were 
given. Patient was discharged after complete recovery from illness. Then 
patients were regularly followed and managed. 
DISCUSSION AND ANALYSIS 
The observations and results of this study were compared with previous 
studies and the results were analysed. 
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This study includes 34 cases of gastric outlet obstruction in adults. Young 
age of presentation is 30 years and old age is 75 years. Average age of 
presentation is 52.5 years.    
Male patients accounted for 57% of the cases and female patients accounted 
for 43%. In less than 50 years old, 6 were male patients and 8 were female 
patients. In 10 patients the cause was malignant and 4 patients had benign 
lesion. This study shows that the malignant lesion occurs in young age. In 
age between 50 to 55 years 4 patients were male patients and 4 patients were 
female. In 7 patients the cause is malignant lesion and in 1 patient the cause 
is benign lesion. In age 56 to 60 years old patients there were 3 cases and the 
cause is malignant lesion. In age between 61to 65 years there were 6 patients 
and in 4 patients the cause is malignant lesion. In 2 patients the cause is 
benign lesion. Malignancy is the cause in 3 patients above 65 years old. 
In 14 patients the blood group is “B” and in 8 patients the blood group is 
“A”. In 8 patients the blood group is “O” and in 4 patients the blood group is 
“AB”. 
The causes of gastric outlet obstruction in 34 patients were as follows 
 In 26 patients the cause was carcinoma stomach, 
In 7 patients the cause was cicatrized duodenal ulcer, 
In 1 patient the cause was chronic ulcer in pyloric antrum. 
In carcinoma stomach 14 patients had moderately differentiated 
adenocarcinoma, 
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10 patients had poorly differentiated adenocarcinoma, 2 patients had well 
differentiated adenocarcinoma. 
In 33 patients vomiting was the main complaints and it was projectile, 
effortless, non bilious and contains undigested food particles. 31 patients 
developed abdomen pain which was dull aching and continuous in nature. 
Patient developed  pain immediately after taking food and was relieved by 
vomiting. 30 patients had reduced food intake and had early satiety due to 
which patients were dehydrated and malnourished. 7 patients had episodes of 
blood vomiting and 5 patients had malena. 
Clinically 27 patients were dehydrated due to increased frequency of 
vomiting. Hence patients were malnourished and emaciated. 23 patients had 
weight loss and the weight loss is rapid in malignant lesion.22 patients were 
pallor and anaemic on investigations. In 14 patients there were succussion 
splash and dilated stomach clinically. In 12 patients there were visible gastric 
peristalsis from left hypochondrium to right hypochondrium. Some patients 
had palpable mass in epigatric region.  
All patients were subjected to upper gastrointestinal endoscopy and biopsy 
was taken from the lesion and sent for histopathological study. In 15 patients 
there was ulceroproliferative growth in pyloric region, in 9 patients there was 
ulcerative growth in pyloric region, in 4 patients there was pyloric stenosis 
and the scopy could not be passed beyond the pyloric region, in 3 patients 
there was duodenal ulcer in 1st part of duodenum, in 2 patients there was 
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polypoid growth in pyloric region, in one patient the 1st and 2nd part of 
duodenum was dilated. Many patients had dilated stomach with food debris. 
The present study results and findings were compared and analysis was 
done.  
 Comparison of etiological factors in various studies 
Etiology Present 
study 
Johns 
Hopkins 
Ishra 
university 
JSLS 
study 
Mishra 
study 
 No: % No % No % No % No % 
Malignant 26 74 20 61 27 51.9  16 57 56 76 
Benign 8 26 13 39  25 48.1 12 43 18 24 
Total  34 100 33 100 52 100 28 100 74 100 
 
From various studies the commonest cause of gastric outlet obstruction was 
found to be malignant lesion. The present study values are close to values 
observed in mishra study. The cause of rise in malignancy was due to the use 
of H2 blockers, proton pump inhibitor, eradication of helicobactor pylori 
infection. 
In present study upper gastrointestinal endoscopy was done in 34 cases 
(100%), and biopsy sent for histopathological study. 26 patients (74%) had 
carcinoma antrum pyloric region, 7 patients (20%) had  cicatrized  duodenal 
ulcer, 1 patients (6%) had gastric ulcer in pyloric region. 
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In this study 7 patients with cicatrized duodenal ulcer underwent truncal 
vagotomy with posterior gastrojejunostomy. One patient with gastric ulcer in 
pyloric region underwent distal gastrectomy with gastro jejunostomy. 
Among 26 patients with gastric carcinoma in pyloric region, 14 of them with 
advanced gastric carcinoma underwent  anterior gastro jejunostomy as a 
palliative procedure. In all these patients the tumor was in operable and 
curative surgery was not possible. In 6 patients partial gastrectomy with 
gastro jejunostomy was done. In 2 patients total gastrectomy with 
oesophagus  jejunostomy and feeding  jejunostomy was done. In 3 patients  
distal gastrectomy with gastro jejunostomy was done. In one patient subtotal 
gastrectomy with gastro jejunostomy was done. One patient with advanced 
gastric carcinoma underwent feeding jejunostomy as a palliative procedure. 
CONCLUSION 
The present study is a pathological study on gastric outlet obstruction. The 
observations from the data and results obtained in the present study were  
 Male patients are more commonly affected by gastric outlet obstruction. 
Carcinoma in pyloric antral region was the most common cause of gastric 
outlet obstruction. 
Vomiting and dehydration are the common symptoms and signs of gastric 
outlet obstruction. 
Upper gastro intestinal endoscopy and biopsy are the Gold standard 
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investigation for gastric outlet obstruction. It has been used for both 
diagnostic purpose and taking biopsy from the lesion. 
Patient general condition, correction of anemia, fluid and electrolyte 
imbalance and preparation of stomach must be done preoperatively.  
Patients with gastric outlet obstruction due to cicatrized duodenal ulcer 
require truncal vagotomy with posterior gastrojejunostomy. 
In patients with carcinoma pyloric antral region require curative surgery in 
early stage or a palliative surgery depending on the stage of the disease. 
All patients above 40 years with symptoms of dyspepsia should   undergo 
upper gastro intestinal endoscopy and biopsy examination. 
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PROFORMA 
 
            Name:                                               Age: 
                                                   
            Sex:                                                   I.P. No.: 
 
            Occupation: 
 
            DOA:                                                DOS: 
                                                     
            DOD: 
 
            Income:                                             Address:                                              
 
            Chief Complaints 
 
             A. Pain abdomen --                         B. Vomiting- 
                                                
             C. Mass per abdomen --                  D. Others - 
 
            History of Presenting Illness 
 
A. Abdominal pain 
 
                   Duration:                    Site:               Nature:        Relation to food: 
 
  Radiation:                   Periodicity:                        Aggravating 
factors: 
  
                  Relieving factors: 
 
B. Vomiting 
 
                     Duration:                        Frequency:                Quantity: 
 
                     Relation to food: 
 
                     Induced/Spontaneous:     Projectile/Regurgitant: 
 
                     Digested/Undigested:                             Foul smelling: 
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                     Bile/Blood: 
 
C. Mass per abdomen 
 
                    Duration:                        Site:                             Progress: 
 
                   Ball rolling movement: 
 
D. Post-prandial fullness 
 
E. Malena / Haematemesis 
 
            F. Loss of appetite 
 
            G. Loss of weight 
 
H.  Associated symptoms 
 
                    Fever 
 
                   Occupation 
                   Jaundice 
 
                   Abdominal distension 
 
                   Others 
 
     Past History: History of peptic ulcer disease  
 
    Family History:             Married/Unmarried 
 
     History of peptic ulcer disease/deaths due to carcinoma stomach/ 
tuberculosis. 
 
 
 
   Personal History: 
 
     A. Diet: Vegetarian/Mixed               Spicy: Yes/No 
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                    Irregular food habits: Yes/No 
 
     B. Smoking:        Type:        Quantity:          Duration: 
 
    C. Alcohol intake:     Type:         Quantity:         Frequeny:   Duration:                                                             
 
    D. Tobacco chewing: 
 
E. Micturition:                            Menstrual history: 
 
    General Physical Examination 
 
    Built:                    Pulse:                Blood pressure: 
 
    Nourishment:       Pallor:               Cachexia:                     Icterus: 
 
    Signs of dehydration:                    Lymphadenopathy: 
  
 Systemic Examination 
 
  Respiratory system:                  Cardio vascular system: 
 
  Abdominal Examination 
 
   Inspection:                         Distension:                   Visible gastric 
peristalsis: 
 
   Palpation:                           Site of tenderness: 
 
   Mass:         Tenderness:             Site:                      Size: 
 
                      Shape:                     Surface:                Consistency: 
 
                     Movement with respiration:                 Mobility: 
 
   Organomegaly:                          Succession splash: 
 
   Shifting dullness:                      Auscultopercussion: 
 
   Per rectal digital examination:  Per vaginal examination: 
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Investigations 
 
A. Routine Investigations 
 
        Blood: Haemoglobin %        Bleeding time:                Clotting time: 
 
        Blood glucose: mg%             Blood urea: mg%         Serum creatinine: 
mg% 
 
        Blood group:                        Serum electrolytes: 
 
       Urine:  Albumin:          Sugar:                 Microscopy: 
 
       Stool:   Ova/Cyst         Occult blood: 
 
      Chest X-ray/Screening 
 
      ECG in all leads: 
 
      Upper Gastrointestinal Endoscopy/ Biopsy 
  
      Ultra sonogram of Abdomen 
 
      Pre-operative Management: 
 
     Surgery: 
 
     Date of surgery:                    Anaesthesia:                         Incision: 
 
     Findings: 
 
    Procedure: 
 
 Histopathological report: 
 
 Final Diagnosis 
 
 Post-operative management: 
 
 Complications: 
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Post-operative treatment: Chemotherary/Radiotherapy 
 
Outcome:           Date of Discharge:                  Condition: 
 
Advice: 
 
Follow-up: 
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ANNEXURE II 
 
                                            CONSENT FORM 
 
                                       For Operation / Anesthesia 
 
I______________Hosp. No._______________ in my full senses hereby give 
 
my complete consent for ______________ or any other procedure deemed 
fit  
 
which is a/ and diagnostic procedure / biopsy / transfusion / operation to be 
  
performed on me / my ward______________ age ____________under any 
 
 anesthesia deemed fit. The nature and risks involved in the procedure have 
been 
 
 explained to me to my satisfaction. For academic and scientific purpose, the 
 
 operation / procedure may be televised or photographed. 
 
 
 
Date:                                                                            Signature / Thumb 
impression 
 
Name:                                                                          of patient / Guardian 
 
                                                      Designation: 
 
                                                     Guardian 
 
                                                     Relationship: 
 
                                                     Full Address 
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S.NO NAME AGE/YRS SEX I.P.NO Bl:GROUP
1 ARUNACHALAM 62 M 39878 B+ve
2 GOMATHY 40 F 57027 B+ve
3 THAVASIRAJAN 60 M 55130 B+ve
4 PANDIAN 65 M 58068 O+ve
5 GOMATHI 55 F 53908 B+ve
6 ARUMUGAM 55 M 55826 AB+ve
7 CHELLAMMAL 55 F 50038 A+ve
8 SUDALAIMUTHU 75 M 42664 A+ve
9 RAJAMANI 65 M 10288 A‐ve
10 AADINACHIYAR 55 F 16649 AB+ve
11 KUMAR 47 M 15487 B+ve
12 SUNDAR 48 M 39244 B+ve
13 GOMATHI 60 F 9653 O+ve
14 CHOKKALINGAM 65 M 27941 A+ve
15 RATHINASAMY 35 M 26665 A+ve
16 MUNIYANDI 51 M 26764 A+ve
17 VANAMAMALAI 50 M 49828 B+ve
18 VIMALA LINCY THANGAM 61 F 33249 A+ve
19 LAXMI 55 F 33888 B+ve
20 MUTHULAKSHMI 47 F 31290 A+ve
21 PATTURAJ 39 M 37201 B+ve
22 SHANMUGAIAH 68 M 32495 B‐ve
23 MUTHAMMAL 60 F 39234 AB+ve
24 ANGAMMAL 41 F 38554 O+ve
25 MAHESWARI 41 F 41510 B+ve
26 CHELLAMMAL 30 F 7708 AB+ve
27 ANNABABU 50 F 50670 A+ve
28 BOOTHAPAANDI 75 M 16010 B+ve
29 PALANI 48 M 2033 AB+ve
30 RAMALAKSHMI 49 F 7805 O+ve
31 KURUVIAMMAL 48 F 33931 O+ve
32 AMMAPONNU 45 F 53172 O+ve
33 ARUNACHALADEVAR 66 M 8346 O+ve
34 MADASAMY 47 M 43566 O+ve
NAME
ARUNACHALAM
GOMATHY
THAVASIRAJAN
PANDIAN
GOMATHI
ARUMUGAM
CHELLAMMAL
SUDALAIMUTHU
RAJAMANI
AADINACHIYAR
KUMAR
SUNDAR
GOMATHI
CHOKKALINGAM
RATHINASAMY
MUNIYANDI
VANAMAMALAI
VIMALA LINCY THANGAM
LAXMI
MUTHULAKSHMI
PATTURAJ
SHANMUGAIAH
MUTHAMMAL
ANGAMMAL
MAHESWARI
CHELLAMMAL
ANNABABU
BOOTHAPAANDI
PALANI
RAMALAKSHMI
KURUVIAMMAL
AMMAPONNU
ARUNACHALADEVAR
MADASAMY
UPPER GASTRO INTESTINAL ENDOSCOPY
 1st AND  2nd PART OF DUODENUM  DILATED 
ULCEROPROLIFERATIVE MASS PRESENT IN PYLORIC REGION
ULCEROPROLIFERATIVE GROWTH PRESENT IN PYLORIC REGION
ULCEROPROLIFERATIVE MASS PRESENT IN PYLORIC REGION
ULCERATIVE GROWTH IN PYLORUS REGION
ULCEROPROLIFERATIVE GROWTH PRESENT IN PYLORIC REGION
ULCERATIVE GROWTH IN PYLORUS REGION
ULCEROPROLIFERATIVE GROWTH PRESENT IN PYLORIC REGION
 ULCER IN PYLORUS REGION WITH STENOSIS IN PYLORIC REGION
POLYPOID GROWTH IN PYLORUS REGION
ULCEROPROLIFERATIVE GROWTH PRESENT IN PYLORIC REGION
ULCEROPROLIFERATIVE GROWTH PRESENT IN PYLORIC REGION ALONG LESSER CURVATURE
ULCEROPROLIFERATIVE GROWTH PRESENT IN PYLORIC REGION ALONG LESSER CURVATURE
DILATED STOMACH WITH ULCEROPROLIFERATIVE GROWTH PRESENT IN PYLORIC REGION
ULCEROPROLIFERATIVE GROWTH PRESENT IN PYLORIC REGION
DILATED STOMACH WITH ULCEROPROLIFERATIVE GROWTH PRESENT IN PYLORIC REGION
PYLORIC STENOSIS WITH DILATATION, SCOPY COULD BE PASSED BEYOND PYLORUS
ULCEROPROLIFERATIVE GROWTH PRESENT IN PYLORIC REGION ALONG LESSER CURVATURE
 GROWTH PRESENT IN PYLORIC REGION ALONG LESSER CURVATURE
PYLORUS LINITIS PLASTICA
GASTRIC EROSION , ULCER IN PYLORUS, DUODENAL ULCER WITH GASTRIC  OBSTRUCTION
 ULCER IN 1st PART OF DUODENUM
ULCEROPROLIFERATIVE GROWTH PRESENT IN PYLORIC REGION ALONG GREATER CURVATURE
ULCEROPROLIFERATIVE GROWTH PRESENT IN PYLORIC REGION ALONG GREATER CURVATURE
ULCEROPROLIFERATIVE GROWTH PRESENT IN PYLORIC REGION ALONG GREATER CURVATURE
DUODENAL ULCER WITH LUMEN NARROWING IN 1st PART, SCOPY COULD NOT BE PASSED BEYO
ULCEROPROLIFERATIVE GROWTH PRESENT IN PYLORIC REGION
ULCEROPROLIFERATIVE GROWTH PRESENT IN PYLORIC REGION ALONG GREATER CURVATURE
SUPERFICIAL ULCERATIVE LESION IN PYLORUS REGION
ULCEROPROLIFERATIVE GROWTH PRESENT IN PYLORIC REGION
ULCEROPROLIFERATIVE GROWTH PRESENT IN PYLORIC REGION
DUODENAL ULCER WITH OUTLET OBSTRUCTION
ULCERATIVE GROWTH IN PYLORUS REGION
STOMACH GROSSLY DILATED , PYLORIC OPENING STENOSED, SCOPY COULD NOT BE PASSED BEY
NAME
ARUNACHALAM
GOMATHY
THAVASIRAJAN
PANDIAN
GOMATHI
ARUMUGAM
CHELLAMMAL
SUDALAIMUTHU
RAJAMANI
AADINACHIYAR
KUMAR
SUNDAR
GOMATHI
CHOKKALINGAM
RATHINASAMY
MUNIYANDI
VANAMAMALAI
VIMALA LINCY THANGAM
LAXMI
MUTHULAKSHMI
PATTURAJ
SHANMUGAIAH
MUTHAMMAL
ANGAMMAL
MAHESWARI
CHELLAMMAL
ANNABABU
BOOTHAPAANDI
PALANI
RAMALAKSHMI
KURUVIAMMAL
AMMAPONNU
ARUNACHALADEVAR
MADASAMY
HISTO PATHOLOGICAL REPORT REPORT SURGERY
DUODENAL ULCER WITH GASTRIC OUTLET OBSTRUCTION TV/PGJ
POORLY DIFFERENTIATED ADENO CARCINOMA PG/GJ
WELL DIFFERENTIATED ADENO CARCINOMA AGJ
POORLY DIFFERENTIATED ADENO CARCINOMA TG/OJ
POORLY DIFFERENTIATED ADENO CARCINOMA AGJ
MODERATELY DIFFERENTIATED ADENOCARCINOMA AGJ
MODERATELY DIFFERENTIATED ADENOCARCINOMA AGJ
MODERATELY DIFFERENTIATED ADENOCARCINOMA PG/GJ
CHRONIC GASTRIC ULCER WITH OUTLET OBSTRUCTION DG/GJ
MODERATELY DIFFERENTIATED ADENOCARCINOMA AGJ
MODERATELY DIFFERENTIATED ADENOCARCINOMA DG/GJ
POORLY DIFFERENTIATED ADENO CARCINOMA AGJ
MODERATELY DIFFERENTIATED ADENOCARCINOMA AGJ
POORLY DIFFERENTIATED ADENO CARCINOMA AGJ
POORLY DIFFERENTIATED ADENO CARCINOMA PG/GJ
POORLY DIFFERENTIATED ADENO CARCINOMA SG/GJ
PYLORIC STENOSIS WITH GASTRIC DILATATION TV/PGJ
MUCINOUS ADENOCARCINOMA TG/OJ/FJ
MODERATELY DIFFERENTIATED ADENOCARCINOMA AGJ
MODERATELY DIFFERENTIATED ADENOCARCINOMA AGJ
DUODENAL ULCER WITH GASTRIC OUTLET OBSTRUCTION TV/PGJ
CHRONIC DUODENAL ULCER WITH OUTLET OBSTRUCTION TV/PGJ
MODERATELY DIFFERENTIATED ADENOCARCINOMA PG/GJ
POORLY DIFFERENTIATED ADENO CARCINOMA PG/GJ
POORLY DIFFERENTIATED ADENO CARCINOMA PG/GJ
DUODENAL ULCER WITH GASTRIC OUTLET OBSTRUCTION TV/PGJ
WELL DIFFERENTIATED ADENO CARCINOMA TG/OJ
MODERATELY DIFFERENTIATED ADENOCARCINOMA PG/GJ
MODERATELY DIFFERENTIATED ADENOCARCINOMA AGJ
MODERATELY DIFFERENTIATED ADENOCARCINOMA AGJ
MODERATELY DIFFERENTIATED ADENOCARCINOMA AGJ
CHRONIC DUODENAL ULCER WITH OUTLET OBSTRUCTION TV/PGJ
MODERATELY DIFFERENTIATED ADENOCARCINOMA CT
DUODENAL ULCER WITH GASTRIC OUTLET OBSTRUCTION TV/PGJ
NAME
ARUNACHALAM
SUBBAMMAL
THAVASIRAJAN
PANDIAN
GOMATHI
NARAYANAN
CHELLAMMAL
SUDALAIMUTHU
RAJAMANI
AADINACHIYAR
KUMAR
SUNDAR
GOMATHI
CHOKKALINGAM
RATHINASAMY
MUNIYANDI
VANAMAMALAI
VIMALA LINCY THANGAM
LAXMI
HARICHANDRAN
PATTURAJ
MUTHU
MUTHAMMAL
ANGAMMAL
MAHESWARI
CHELLAMMAL
ANNABABU
BOOTHAPAANDI
PALANI
RAMALAKSHMI
KURUVIAMMAL
CHELLAIAH
ARUNACHALADEVAR
MADASAMY
PER OPERATIVE FINDING
DILATED STOMACH, CICATRIZED ULCER IN 1st PART OF DUODENUM
STOMACH GROSSLY DILATED, MASS OF 3 X 3 CMS IN  PYLORIC  REGION
ULCEROPROLIFERATIVE MASS IN PYLORIC REGION 
MASS IN ANTRUM FIXED TO POSTERIOR STOMACH BED STRUCTURES
ULCERATIVE MASS  IN PYLORIC REGION
ASCITES, GROWTH IN PYLORIC PART, SEROSAL INVOLVEMENT
STOMACH GROSSLY DILATED, MASS IN  PYLORIC  REGION
STOMACH DILATED, MASS OF 12 X 7 CMS IN PYLORIC REGION
ULCER 1 X 1 CM  IN PYLORIC ANTRUM WITH STENOSIS IN PYLORUS
POLYPOID MASS OF IN PYLORIC REGION
MASS OF 5 X 3 CMS IN PYLORIC REGION
MASS OF IN PYLORIC REGION
ULCERATIVE MASS OF  IN PYLORIC REGION
ULCEROPROLIFERATIVE GROWTH OF IN PYLORIC REGION 
ULCERPROLIFERATIVE GROWTH OF 10 X 4 CMS IN PYLORIC REGION
GROWTH OF 5 X 3 CMS IN PYLORIC REGION
DILATED STOMACH, CICATRIZED ULCER IN PYLORUS
ANTERIOR WALL INFILTRATION, LIVER METASTSIS, ASCITES
MASS  IN PYLORUS
MASS IN ANTRUM FIXED TO POSTERIOR STOMACH BED STRUCTURES
DILATED STOMACH CICATRIZED DUODENAL ULCER IN 1st PART OF DUODENUM
STOMACH  DILATED, CICATRIZED ULCER IN 1st PART OF DUODENUM
GROWTH IN PREPYLORIC REGION OF 7 X 6 CMS
MASS OF 6 X 2 CMS IN PYLORIC REGION
ULCEROPROLIFERATIVE GROWTH OF 8 X 5 CMS IN PYLORIC REGION 
DILATED STOMACH, CICATRIZATION IN PYLORUS WITH PYLORIC OBSTRUCTION
MASS OF 9 X 5 CMS IN PYLORIC REGION
MASS OF 6 X 4 CMS IN PYLORIC REGION
GROWTH IN STOMACH WITH METASTASES IN LIVER, SIGMOID COLON
GROWTH IN PYLORIC REGION
GROWTH IN PYLORIC REGION
 DILATED STOMACH WITH CICATRIZED ULCER IN PYLORIC ANTRUM 
GROWTH IN PYLORIC REGION
CICATRIZED DUODENAL ULCER IN 1st PART OF DUODENUM
